FR901228 in Treating Patients With Hematologic Cancer

NCT00024180 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: romidepsin

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]